- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04081896
Evaluation of the Effects of a Rehabilitation Program in Individuals With Spine Pain
Evaluation of the Effects of Exercise-based Rehabilitation in Individuals With Spine Pain
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The key objectives for this registry are to 1) identify magnitudes of clinical improvements with this specific specialized rehabilitation program in its various formats (in-clinic vs online), in individuals with or without spine pain for comparison to literature-based standard of care values for other conservative care protocols, 2) to identify average value of this treatment approach based on cost assessment, 3) to identify which patients (based on patient-specific predictors) are most likely to succeed with this specialized program and 4) to identify targets for improvement and optimization of patient care any necessary modifications to the industry's standard for care protocol. The goal of this project is to assess the impact of a standardized program based on core strengthening using technologic monitoring in a multidisciplinary format.
This registry of data will not contain individual identifiers.
The study population is comprised of skeletally mature patients, both male and female, from a wide variety of ethnicities representative of the typical population presenting with spinal conditions, pain, or seeking prevention of future injury. There are no child participants, as they are not candidates for the type of programs under investigation.
All data relating to the patient's physical therapy, diagnosis, co-morbidies, medical history, medications etc., will be used for analysis.
STUDY METHODS:
Describe how the data will be identified:
Approved SpineZone staff will extract relevant outcomes data from the Electronic Medical Records system housed on a secure server. Identifiers will be stripped from the data, and claims will be indexed using Coding processes. Investigators will not have access to the pre-coded identifiers. Age, but not date of birth will be used, but no patients over the age of 89 will be included, thus it will not be an identifier. All systems used to store and view the data will be secure, with password protections and login access required. Once initial data extraction and de-identification is complete, the de-identified data will be stored on secure servers in a HIPAA compliant environment, and only transferred for biostatistics analytics through encrypted and password protected email to approved individuals (i.e. research biostatisticians) following a data use agreement.
- Data that will be used:
Outcome variables: Validated questionnaire-based outcomes including but not limited to: VAS (visual analogue scale), ODI (oswestry disability index) for Low Back Pain, NDI (neck disability index) for neck pain, PSFS (patient specific functional scale), SBST (STarT Back Screening Tool), Hospital Anxiety and Depression Scale (HADS), medication usage (type, frequency), number of visits, progression to surgery (yes, no), dropout rates and reasons, Online compliance matrix(including access to educational material, log in rates, and self-reporting of compliance with workout regimen); physical examination measurements: strength and ROM measurements, and cost (based on procedural codes).
Predictor variables: Demographic, medical history, and treatment-specific variables including but not limited to: age, gender, ethnicity, diagnosis code (ICD-9/10), SpineZone rehabilitation diagnosis, treatment type, treatment history, radiologic diagnosis, duration of symptoms, postural factors, questionnaire-based pre-treatment disability, psychosocial status, prior treatments, concurrent treatments (e.g., nutrition, mindfulness), and pain scores.
d) Who will identify data to be reviewed:
SpineZone clinical staff and Principal Investigator
CONFIDENTIALITY OF DATA:
Data that is identified by the primary investigator for review will be additionally checked for any identifiers and stripped prior to analysis by biostatisticians. This data will be stored in two places. Initially, the de-identified data will be stored in the biostatistician's system for analysis. Once initial analysis is complete, the data will be loaded into a secure server with physical 24-hour security preventing unauthorized access to the hardware, with access to data only allowed through HTTPS login or through a direct and secure tunnel. Only investigators will have access to the login information.
Within two months of completion of the study, biostatisticians copy of the data will be destroyed. The data will be maintained in the secure hosted environment indefinitely.
Data will be transmitted with either password protection or PGP encryption on biostatistician computers. These computers and associated hardware are maintained in a secured facility with no public access. Computers are password protected and after 30 minutes of inactivity require the user to login again. Data and programs are backed up on a daily basis during the active phase of any project. Internet access is firewall protected. Anti-virus software is maintained (McAfee) with all incoming and outgoing documents scanned for viruses. Additionally, a scan of all files is performed daily.
Data storage will be on secure servers at a 24-hour guard facility, on windows server systems with updated enterprise virus protection software from Symantec. The database will only be accessible through an HTTPS log-in, with user-based access levels that ensure only personnel authorized by the principal investigator can gain access to the system. Any access will be tracked through a log of historical events that will track what user viewed or manipulated what data at any time.
Systems, security policies, and access logs will all be available for audit and review by the Principal Investigator at any time.
CONSENT:
Consent will be obtained in clinic, or through a form on an online portal for patients participating in the online treatment arm.
RISKS AND BENEFITS:
Risks: A confidentiality breach is a risk associated with data review research, however every measure will be instituted to ensure that patient information is kept confidential. Data analysis worksheets will be kept separate from EMR records. No subject PHI will be collected or shared.
Benefits: The participants are not likely to receive any benefit from the proposed research; however, society and investigators will benefit from the knowledge gained.
STATISTICAL CONSIDERATIONS:
As this is intended to be a data registry, no current statistical analyses are being proposed. Independent sub-studies utilizing data from this registry will be required to provide power analyses and proposed sample sizes necessary to carry out the objectives of the individual research question.
Data will be analyzed for individual sub-studies by biostatisticians located at the University of California, San Diego. All individuals participating in data analysis will be trained in research compliance, ethics, and will follow regulations according to the approved data use agreements in place.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Kamshad Raiszadeh, M.D.
- Phone Number: 858-337-6909
- Email: kam@spinezone.com
Study Contact Backup
- Name: Jon Wu, P.A.
- Phone Number: 858-337-6909
- Email: jonwu@spinezone.com
Study Locations
-
-
California
-
San Diego, California, United States, 92108
- Recruiting
- SpineZone
-
Contact:
- Kamshad Raiszadeh, M.D
- Phone Number: 858-337-6909
- Email: kam@spinezone.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- over 18 years of age
- under 89 years of age
- Patients who have been prescribed physical rehabilitation for management of spine pain
Exclusion Criteria:
- under 18 years of age
- over 89 years of age
- Patients who are unable or medically unsafe to participate in physical rehabilitation for management of spine pain as determined by the prescribing physician
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
In Clinic Rehabilitation
Participants who are undergoing supervised exercise based rehabilitation in the SpineZone clinic
|
Exercise prescribed to participants includes spine-specific strengthening exercises targeting core musculature (i.e. Multifidus, Erector Spinae, Transversus Abdominus, Obliques, and Rectus Abdominus). The in-clinic exercise program recommends a minimum of 20 visits at 2 visits/week, with a goal of 24 total visits over a 12-week period. Exercise is progressed by 5-10% of their exercise load once they are able to do >20 repetitions. If they are able to reach >10 but <20 repetitions, exercise load remains the same. If they are unable to reach 10 repetitions, exercise load is decreased 5-10% at their next visit. The online exercise program includes non-machine based home exercises targeting the same muscles of interest, and are personalized to each participant based on their home resources and comfort level. Concurrent interventions may or may not include nutrition education, mindfulness, cognitive behavioral therapy. |
Online Rehabilitation
Participants who will be undergoing online-based coaching and exercise as prescribed via telephone, online chat, or web-based interactions with SpineZone rehabilitation staff (physical therapists and physicians)
|
Exercise prescribed to participants includes spine-specific strengthening exercises targeting core musculature (i.e. Multifidus, Erector Spinae, Transversus Abdominus, Obliques, and Rectus Abdominus). The in-clinic exercise program recommends a minimum of 20 visits at 2 visits/week, with a goal of 24 total visits over a 12-week period. Exercise is progressed by 5-10% of their exercise load once they are able to do >20 repetitions. If they are able to reach >10 but <20 repetitions, exercise load remains the same. If they are unable to reach 10 repetitions, exercise load is decreased 5-10% at their next visit. The online exercise program includes non-machine based home exercises targeting the same muscles of interest, and are personalized to each participant based on their home resources and comfort level. Concurrent interventions may or may not include nutrition education, mindfulness, cognitive behavioral therapy. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in pain: Visual Analogue Scale (VAS), 0-100mm
Time Frame: 3 months, 6 months, 1 year, and 2 years
|
difference in VAS (in mm) between initial evaluation and endpoint
|
3 months, 6 months, 1 year, and 2 years
|
Change in disability (%)
Time Frame: 3 months, 6 months, 1 year, and 2 years
|
difference in Neck Disability Index (for neck pain participants) or Oswestry Disability Index (for Low Back Pain participants), or Scoliosis Research Society Outcomes questionnaire-22 (for Scoliosis participants) between initial evaluation and endpoint
|
3 months, 6 months, 1 year, and 2 years
|
Change in quality of life
Time Frame: 3 months, 6 months, 1 year, and 2 years
|
difference in EQ5-D (points) score between initial evaluation and endpoint
|
3 months, 6 months, 1 year, and 2 years
|
Change in strength (lbs*deg)
Time Frame: 3 months, 6 months, 1 year, and 2 years
|
difference in spine extension torque as measured by isokinetic dynamometer between initial evaluation and endpoint
|
3 months, 6 months, 1 year, and 2 years
|
Change in Range of Motion (deg)
Time Frame: 3 months, 6 months, 1 year, and 2 years
|
difference in total spine flexion and extension (in degrees) between initial evaluation and endpoint
|
3 months, 6 months, 1 year, and 2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in spine extensor muscle cross sectional area (cm2)
Time Frame: 3 months
|
Difference in cross sectional area of the multifidus and erector spinae muscles as measured via MRI between initial evaluation and endpoint
|
3 months
|
change in spine extensor muscle fatty infiltration (%)
Time Frame: 3 months
|
difference in percentage of fat within the multifidus and erector spinae muscles as measured by T1-weighted MRI between initial evaluation and endpoint
|
3 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in medication usage (category)
Time Frame: 3 months, 6 months, 1 year, and 2 years
|
difference in frequency of analgesic medication usage between initial evaluation and endpoint: frequency will be aggregated according to the following categories: [None, <1/day, 1-2/day, 3+/day]
|
3 months, 6 months, 1 year, and 2 years
|
Surgery (%)
Time Frame: 6 months, 1 year, and 2 years
|
Percentage of participants that cross over into a surgical intervention
|
6 months, 1 year, and 2 years
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Bahar Shahidi, P.T., Ph.D., University of California, San Diego
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Spine Exercise
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Low Back Pain
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Faculdade de Ciências Médicas da Santa Casa de...CompletedLow Back Pain, Mechanical | Low Back Pain, Postural | Lower Back Pain Chronic | Low Back Pain, Posterior CompartmentBrazil
-
University School of Physical Education in WroclawCompletedLow Back Pain | Low Back Pain, Mechanical | Low Back Pain, PosturalPoland
-
Texas Woman's UniversityTexas Physical Therapy AssociationCompletedLow Back Pain | Chronic Low Back Pain | Subacute Low Back PainUnited States
-
University of ParmaKing's College London; Helmholtz Zentrum München; GENOS; Ip Research Consulting... and other collaboratorsUnknownChronic Low Back Pain | Acute Low Back PainUnited States, Australia, Belgium, Croatia, Italy, United Kingdom
-
Ache Laboratorios Farmaceuticos S.A.Unknown
-
Palmer College of ChiropracticDepartment of Health and Human ServicesCompletedChronic Low Back Pain | Subacute Low Back PainUnited States
-
Universität Duisburg-EssenSiemens-BetriebskrankenkasseCompletedChronic Low Back Pain | Recurrent Low Back Pain
-
Karolinska InstitutetCompletedChronic Low Back Pain | Recurrent Low Back Pain | Persistent Low Back PainSweden
-
Apsen Farmaceutica S.A.CompletedLow Back Pain | Low Back Pain, Mechanical | Acute Low Back PainBrazil
Clinical Trials on Exercise
-
University of Kansas Medical CenterRecruiting
-
National Institute of Neurological Disorders and...TerminatedTraumatic Brain InjuryUnited States
-
University of Texas, El PasoRecruitingKnee Osteoarthritis | Knee Pain Chronic | Central Pain SyndromeUnited States
-
Toronto Rehabilitation InstituteCompletedAcute Myeloid LeukemiaCanada
-
Sahmyook UniversityRecruitingChronic Nonspecific Neck PainKorea, Republic of
-
University of AlbertaWomen and Children's Health Research Institute, CanadaRecruitingType 1 Diabetes | Post-menopauseCanada
-
Uskudar UniversityCompleted
-
Yuksek Ihtisas UniversityCompletedDementia | Frailty | Cognitive Function | Reaction Time | Aerobic Exercise | Balance ExerciseTurkey
-
National Taiwan Normal UniversityCompletedAging | Cognitive DeclineTaiwan
-
Wayne State UniversityUnknown